期刊
CELLS
卷 8, 期 4, 页码 -出版社
MDPI
DOI: 10.3390/cells8040357
关键词
beta-3 adrenergic receptor; therapeutic target; G-protein coupled receptors
类别
资金
- NIH [NIH RO1 DK072612, NIH PO1 DK-17433]
The beta-3 adrenergic receptor ((3)-AR) is by far the least studied isotype of the beta-adrenergic sub-family. Despite its study being long hampered by the lack of suitable animal and cellular models and inter-species differences, a substantial body of literature on the subject has built up in the last three decades and the physiology of (3)-AR is unraveling quickly. As will become evident in this work, (3)-AR is emerging as an appealing target for novel pharmacological approaches in several clinical areas involving metabolic, cardiovascular, urinary, and ocular disease. In this review, we will discuss the most recent advances regarding (3)-AR signaling and function and summarize how these findings translate, or may do so, into current clinical practice highlighting (3)-AR's great potential as a novel therapeutic target in a wide range of human conditions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据